Insights for Stratification of Risk in Brugada Syndrome

Brugada syndrome (BrS) is an inherited disease with an increased risk of sudden cardiac death (SCD). However, testing identifies genetic disorders in only 20-30% of patients analysed, indicating a gap in knowledge of its genetic aetiology. Diagnosis relies on ECG, and risk stratification in BrS pati...

Full description

Saved in:
Bibliographic Details
Published inEuropean cardiology Vol. 14; no. 1; pp. 45 - 49
Main Authors Iglesias, Daniel García, Rubín, José, Pérez, Diego, Morís, César, Calvo, David
Format Journal Article
LanguageEnglish
Published England Radcliffe Cardiology 01.04.2019
Radcliffe Medical Media
Subjects
Heart Failure and Arrhythmias
ECG
risk stratification
sudden cardiac death
Brugada syndrome
patient management
Online AccessGet full text

Cover

More Information
Summary:Brugada syndrome (BrS) is an inherited disease with an increased risk of sudden cardiac death (SCD). However, testing identifies genetic disorders in only 20-30% of patients analysed, indicating a gap in knowledge of its genetic aetiology. Diagnosis relies on ECG, and risk stratification in BrS patients is challenging, primarily because of the complexity of the issue. As a result, clinicians fail to provide the appropriate strategy for SCD prevention for many patients. Several variables and interventions are being studied to improve diagnostics and maximise patient protection. In addition, the scientific community must increase efforts to provide patient care according to knowledge and research for improving stratification of risk. In this article, the authors summarise contemporary evidence on clinical variables and provide an overview of future directions in risk stratification and SCD prevention.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Disclosure: The authors have no conflicts of interest to declare.
ISSN:1758-3756
1758-3764
DOI:10.15420/ecr.2018.31.2